Senior team members at RM Global have advised on and completed the following transactions and assignments:
Asset Acquisition
Advised GC Biopharma on the foregoing transaction
Global Licensing Agreement
Advised Chong Kun Dang Pharm on the foregoing transaction
Shanghai Easy-Flow Medical Technology Co., Ltd.
Advised Control Medical Technology on the foregoing transaction
Acquisition
Advised Genome & Company on the foregoing transaction
Global Licensing Agreement
Advised Brickell Biotech on the foregoing transaction
Series C Financing
Series A Financing
Advised R3 Vascular on the foregoing transaction
Equity investment in Scioto Biosciences’ Series B and Strategic Collaboration with Scioto Biosciences
Advised Genome & Company on the foregoing transaction
Series B Financing
Advised Adicet Bio on the foregoing transaction
Series A Financing
Advised bioClarity on the foregoing transaction
Series B Financing
Advised Oncologie on the foregoing transaction
Strategic Collaboration & Global Licensing Agreement
Advised BridgeBio Therapeutics on the foregoing transaction